Ck Life Sciences
Ck Life Sciences, also known as Ck Life Sciences International Holdings, is a prominent biotechnology company headquartered in Hong Kong. Founded in 2000, the company has established itself as a leader in the life sciences sector, focusing on innovative solutions in agricultural biotechnology and healthcare. With a strong presence in Asia and expanding operations globally, Ck Life Sciences is dedicated to developing unique products that enhance crop yields and improve human health. Their core offerings include advanced biopesticides and nutraceuticals, distinguished by their commitment to sustainability and efficacy. Recognised for its pioneering research and development, Ck Life Sciences has achieved significant milestones, positioning itself as a key player in the biotechnology industry. The company continues to drive advancements that contribute to a healthier and more sustainable future.
DitchCarbon Score
How does Ck Life Sciences's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Ck Life Sciences's score of 39 is higher than 64% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Ck Life Sciences's reported carbon emissions
In 2024, Ck Life Sciences reported total carbon emissions of approximately 47,495,000 kg CO2e, comprising about 31,245,000 kg CO2e from Scope 1 and about 16,250,000 kg CO2e from Scope 2 emissions. This represents a slight decrease from 2023, where total emissions were about 48,960,000 kg CO2e, with Scope 1 at approximately 32,037,000 kg CO2e and Scope 2 at about 16,923,000 kg CO2e. The company has set a long-term commitment to achieve net-zero emissions by 2050, as outlined in their NGFS Net Zero 2050 initiative, which began in 2019. This commitment encompasses all scopes of emissions, although specific reduction percentages have not been disclosed. Ck Life Sciences does not currently report Scope 3 emissions, and their emissions data is not cascaded from any parent organization. The company is actively working towards enhancing its sustainability practices and reducing its carbon footprint in alignment with industry standards.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Scope 1 | 31,322,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 16,205,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Ck Life Sciences is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
